By Randy EllisStaff writer firstname.lastname@example.orgNORMAN — A recently retired Baylor College of Medicine professor defended several controversial studies that reported quality of life improvements and low addiction rates among certain opioid patient populations Tuesday as testimony resumed in the state's public nuisance case against Johnson & Johnson and its subsidiaries. Testifying as a witness for Johnson & Johnson, Richard De La Garza defended the academic rigor of several studies that the drug company's marketing team had used in promotional materials that were harshly criticized by the federal Food and Drug Administration in a 2004 warning letter. De La Garza testified he thought the studies headed by Milligan, Allan and Simpson were...
READ MORE >
Retired Baylor med school professor defends studies that cited low opioid addiction rates